Key Client Fiduciary Advisors, LLC Cytosorbents Corp Transaction History
Key Client Fiduciary Advisors, LLC
- $196 Million
- Q1 2025
A detailed history of Key Client Fiduciary Advisors, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Key Client Fiduciary Advisors, LLC holds 78,457 shares of CTSO stock, worth $87,087. This represents 0.04% of its overall portfolio holdings.
Number of Shares
78,457
Previous 34,557
127.04%
Holding current value
$87,087
Previous $31,000
151.61%
% of portfolio
0.04%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding CTSO
# of Institutions
57Shares Held
15.8MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.43 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$3.09 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.16 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.87 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.39 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $48.4M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...